Physical Activity Coaching After Surgery for Patients with Resectable Non-small Cell Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

June 1, 2025

Conditions
Non Small Cell Lung CancerNon-small Cell Carcinoma
Interventions
OTHER

Physical activity tele coaching program

"The program includes~1. one-to-one semi-structured interview with the coach discussing the importance of physical activity, motivation, self-efficacy, barriers, favourite activities, and (coping) strategies to become more active resulting in an individual action plan;~2. step counter (Fitbit) providing direct feedback which automatically sends data to the smartphone via blue-tooth. Patients will be asked to wear this step counter every day during the intervention;~3. smartphone coaching application (mPAC), installed on a smartphone and linked to the step counter, will provide automated coaching by displaying an individual activity goal (expressed as daily step count) and daily and weekly feedback on the performance (steps) of the patient.~4. phone calls by the coaches initiated in pre-defined situations (non-compliance with wearing the step counter, failure to transmit the data, failure to progress).~Evidence-based behaviour change techniques will be implemented."

Trial Locations (6)

3500

RECRUITING

Hasselt University, Hasselt

NOT_YET_RECRUITING

Jessa Ziekenhuis, Hasselt

3600

RECRUITING

Ziekenhuis Oost-Limburg, Genk

8000

RECRUITING

AZ Sint-Jan, Bruges

8800

RECRUITING

AZ Delta, Roeselare

9000

RECRUITING

Ghent University Hospital, Ghent

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hasselt University

OTHER

collaborator

AZ Sint-Jan AV

OTHER

collaborator

AZ Delta

OTHER

collaborator

Ziekenhuis Oost-Limburg

OTHER

collaborator

Jessa Hospital

OTHER

lead

University Hospital, Ghent

OTHER

NCT06057766 - Physical Activity Coaching After Surgery for Patients with Resectable Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter